Cargando…

Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial

AIMS: Restoration of myocardial blood flow and perfusion during percutaneous coronary intervention (PCI) measured using Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG) and perfusion grade (TMPG) is associated with improved outcomes in acute coronary syndrome (ACS). Associations between...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Gorav, Renlund, Henrik, Kunadian, Vijay, James, Stefan K, Storey, Robert F, Steg, P Gabriel, Katus, Hugo A, Harrington, Robert A, Gibson, C Michael, Budaj, Andrzej, Siegbahn, Agneta, Wallentin, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173680/
https://www.ncbi.nlm.nih.gov/pubmed/35213721
http://dx.doi.org/10.1093/ehjacc/zuac020
_version_ 1784722073227100160
author Batra, Gorav
Renlund, Henrik
Kunadian, Vijay
James, Stefan K
Storey, Robert F
Steg, P Gabriel
Katus, Hugo A
Harrington, Robert A
Gibson, C Michael
Budaj, Andrzej
Siegbahn, Agneta
Wallentin, Lars
author_facet Batra, Gorav
Renlund, Henrik
Kunadian, Vijay
James, Stefan K
Storey, Robert F
Steg, P Gabriel
Katus, Hugo A
Harrington, Robert A
Gibson, C Michael
Budaj, Andrzej
Siegbahn, Agneta
Wallentin, Lars
author_sort Batra, Gorav
collection PubMed
description AIMS: Restoration of myocardial blood flow and perfusion during percutaneous coronary intervention (PCI) measured using Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG) and perfusion grade (TMPG) is associated with improved outcomes in acute coronary syndrome (ACS). Associations between TFG/TMPG and changes in biomarkers reflecting myocardial damage/dysfunction and inflammation is unknown. METHODS AND RESULTS: Among 2606 patients included, TFG was evaluated in 2198 and TMPG in 1874 with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment ACS (NSTE-ACS). Biomarkers reflecting myocardial necrosis [troponin T (TnT)], myocardial dysfunction [N-terminal prohormone brain natriuretic peptide (NT-proBNP)], inflammation [interleukin-6 (IL-6) and C-reactive protein (CRP)], and oxidative stress/ageing/inflammation [growth differentiation factor-15 (GDF-15)] were measured at baseline, discharge, and 1- and 6-month post-randomization. Associations between TFG/TMPG and changes in biomarker levels were evaluated using the Mann–Whitney–Wilcoxon signed test. In total, 1423 (54.6%) patients had STEMI and 1183 (45.4%) NSTE-ACS. Complete reperfusion after PCI with TFG = 3 was achieved in 1110 (85.3%) with STEMI and in 793 (88.5%) with NSTE-ACS. Normal myocardial perfusion with TMPG = 3 was achieved in 475 (41.6%) with STEMI and in 396 (54.0%) with NSTE-ACS. Levels of TnT, NT-proBNP, IL-6, CRP, and GDF-15 were substantially lower at discharge in patients with complete vs. incomplete TFG and STEMI (P < 0.01). This pattern was not observed for patients with NSTE-ACS. Patients with normal vs. abnormal TMPG and NSTE-ACS had lower levels of NT-proBNP at discharge (P = 0.01). CONCLUSIONS: Successful restoration of epicardial blood flow in STEMI was associated with less myocardial necrosis/dysfunction and inflammation. Attainment of normal myocardial perfusion was associated with less myocardial dysfunction in NSTE-ACS.
format Online
Article
Text
id pubmed-9173680
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91736802022-06-08 Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial Batra, Gorav Renlund, Henrik Kunadian, Vijay James, Stefan K Storey, Robert F Steg, P Gabriel Katus, Hugo A Harrington, Robert A Gibson, C Michael Budaj, Andrzej Siegbahn, Agneta Wallentin, Lars Eur Heart J Acute Cardiovasc Care Original Scientific Paper AIMS: Restoration of myocardial blood flow and perfusion during percutaneous coronary intervention (PCI) measured using Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG) and perfusion grade (TMPG) is associated with improved outcomes in acute coronary syndrome (ACS). Associations between TFG/TMPG and changes in biomarkers reflecting myocardial damage/dysfunction and inflammation is unknown. METHODS AND RESULTS: Among 2606 patients included, TFG was evaluated in 2198 and TMPG in 1874 with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment ACS (NSTE-ACS). Biomarkers reflecting myocardial necrosis [troponin T (TnT)], myocardial dysfunction [N-terminal prohormone brain natriuretic peptide (NT-proBNP)], inflammation [interleukin-6 (IL-6) and C-reactive protein (CRP)], and oxidative stress/ageing/inflammation [growth differentiation factor-15 (GDF-15)] were measured at baseline, discharge, and 1- and 6-month post-randomization. Associations between TFG/TMPG and changes in biomarker levels were evaluated using the Mann–Whitney–Wilcoxon signed test. In total, 1423 (54.6%) patients had STEMI and 1183 (45.4%) NSTE-ACS. Complete reperfusion after PCI with TFG = 3 was achieved in 1110 (85.3%) with STEMI and in 793 (88.5%) with NSTE-ACS. Normal myocardial perfusion with TMPG = 3 was achieved in 475 (41.6%) with STEMI and in 396 (54.0%) with NSTE-ACS. Levels of TnT, NT-proBNP, IL-6, CRP, and GDF-15 were substantially lower at discharge in patients with complete vs. incomplete TFG and STEMI (P < 0.01). This pattern was not observed for patients with NSTE-ACS. Patients with normal vs. abnormal TMPG and NSTE-ACS had lower levels of NT-proBNP at discharge (P = 0.01). CONCLUSIONS: Successful restoration of epicardial blood flow in STEMI was associated with less myocardial necrosis/dysfunction and inflammation. Attainment of normal myocardial perfusion was associated with less myocardial dysfunction in NSTE-ACS. Oxford University Press 2022-02-25 /pmc/articles/PMC9173680/ /pubmed/35213721 http://dx.doi.org/10.1093/ehjacc/zuac020 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Scientific Paper
Batra, Gorav
Renlund, Henrik
Kunadian, Vijay
James, Stefan K
Storey, Robert F
Steg, P Gabriel
Katus, Hugo A
Harrington, Robert A
Gibson, C Michael
Budaj, Andrzej
Siegbahn, Agneta
Wallentin, Lars
Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
title Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
title_full Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
title_fullStr Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
title_full_unstemmed Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
title_short Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
title_sort effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with st-segment and non-st-segment elevation acute coronary syndrome: results from the platelet inhibition and patients outcomes (plato) trial
topic Original Scientific Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173680/
https://www.ncbi.nlm.nih.gov/pubmed/35213721
http://dx.doi.org/10.1093/ehjacc/zuac020
work_keys_str_mv AT batragorav effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT renlundhenrik effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT kunadianvijay effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT jamesstefank effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT storeyrobertf effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT stegpgabriel effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT katushugoa effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT harringtonroberta effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT gibsoncmichael effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT budajandrzej effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT siegbahnagneta effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial
AT wallentinlars effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial